Baron Wealth Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$355K Sell
35,715
-657
-2% -$5.78K 0.09% 170
2026
Q2
$295K Sell
36,372
-1,906
-5% -$14K 0.08% 203
2026
Q1
$245K Buy
38,278
+2,886
+8% +$18.6K 0.07% 220
2025
Q4
$211K Buy
35,392
+13,625
+63% +$72.4K 0.06% 232
2025
Q3
$116K Buy
+21,767
New +$92.3K 0.04% 240

Other funds holding PBYI

Baron Wealth Management's PBYI Position: Q3 2026 in Review

Baron Wealth Management reduced its Puma Biotechnology (PBYI) stake by 1.8% in Q3 2026, selling an estimated $5.78K and leaving 35,715 shares worth $355K. The position accounts for 0.09% of the portfolio, ranked #170.

Baron Wealth Management first reported a position in PBYI in Q3 2025 and has held it in 5 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Baron Wealth Management held 35,715 shares of Puma Biotechnology worth $355K as of Q3 2026.
  • Baron Wealth Management sold 657 Puma Biotechnology shares in Q3 2026, an estimated $5.78K.
  • Puma Biotechnology made up 0.09% of Baron Wealth Management's portfolio in Q3 2026, its #170 holding.
  • Baron Wealth Management first reported a position in Puma Biotechnology in Q3 2025 and has held it in 5 quarters since.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Baron Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.